Serum thyroglobulin determination in thyroid cancer patients

被引：31
作者：
Francis, Zelia [1 ]
Schlumberger, Martin [1 ]
机构：
[1] Univ Paris 09, Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2008年 / 22卷 / 06期
关键词：
thyroglobulin; thyroid cancer; follow-up; neck ultrasonography; recombinant human TSH;
D O I：
10.1016/j.beem.2008.09.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum thyroglobulin determination plays a central role, in combination with neck ultrasonography, in the follow-up of thyroid cancer patients. Its specificity is improved by thyroid remnant ablation, and its sensitivity is optimal following prolonged withdrawal or stimulation with recombinant human thyroid-stimulating hormone (TSH). Modern methods with an improved functional sensitivity may facilitate its use during follow-up.
引用
收藏
页码：1039 / 1046
页数：8
相关论文
共 43 条
  • [1] Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment
    Bachelot, A
    Leboulleux, S
    Baudin, E
    Hartl, DM
    Caillou, B
    Travagli, JP
    Schlumberger, M
    [J]. CLINICAL ENDOCRINOLOGY, 2005, 62 (03) : 376 - 379
  • [2] Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma
    Bachelot, A
    Cailleux, AF
    Klain, M
    Baudin, E
    Ricard, M
    Bellon, N
    Caillou, B
    Travagli, JP
    Schlumberger, M
    [J]. THYROID, 2002, 12 (08) : 707 - 711
  • [3] Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients
    Baudin, E
    Do Cao, C
    Cailleux, AF
    Leboulleux, S
    Travagli, JP
    Schlumberger, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) : 1107 - 1111
  • [4] Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal
    Borget, I.
    Corone, C.
    Nocaudie, M.
    Allyn, M.
    Iacobelli, S.
    Schlumberger, M.
    De Pouvourville, G.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) : 531 - 538
  • [5] Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
    Cailleux, AF
    Baudin, E
    Travagli, JP
    Ricard, M
    Schlumberger, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) : 175 - 178
  • [6] Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels
    Castagna, M. G.
    Brilli, L.
    Pilli, T.
    Montanaro, A.
    Cipri, C.
    Fioravanti, C.
    Sestini, F.
    Capezzone, M.
    Pacini, F.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) : 76 - 81
  • [7] Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma
    Chin, BB
    Patel, P
    Cohade, C
    Ewertz, M
    Wahl, R
    Ladenson, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 91 - 95
  • [8] Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
    Chiovato, L
    Latrofa, F
    Braverman, LE
    Pacini, F
    Capezzone, M
    Masserini, L
    Grasso, L
    Pinchera, A
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) : 346 - 351
  • [9] DEMERS LM, LAB SUPPORT DIAGNOSI
  • [10] Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
    Durante, C.
    Haddy, N.
    Baudin, E.
    Leboulleux, S.
    Hartl, D.
    Travagli, J. P.
    Caillou, B.
    Ricard, M.
    Lumbroso, J. D.
    De Vathaire, F.
    Schlumberger, M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) : 2892 - 2899
12345